| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wettig Thane | CEO, Director | C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO | /s/ Michael Hom, Attorney-in-Fact | 09 Sep 2025 | 0001815638 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FGEN | Common Stock | Tax liability | $1,927 | -246 | -1.1% | $7.83 | 21,487 | 06 Jun 2025 | Direct | F1 |
| transaction | FGEN | Common Stock | Tax liability | $3,001 | -248 | -1.2% | $12.10 | 21,239 | 06 Sep 2025 | Direct | F1 |
| holding | FGEN | Common Stock | 40 | 06 Jun 2025 | By spouse |
| Id | Content |
|---|---|
| F1 | Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
Share amount and share prices reflect a 1-for-25 reverse stock split effective on June 16, 2025.